Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs

PHASE4CompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2011

Conditions
Focal Epilepsy
Interventions
DRUG

Levetiracetam

LEV 250 mg capusles: week 1 and 2 0-0-1, week 3 and 4 1-0-1, week 5: 1-0-2, week 6: 2-0-2. Patients may take 2 to 12 per day (500 - 3000 mg)during maintenance.

DRUG

Carbamazepine

CBZ 100 mg capusles: week 1 and 2: 0-0-1, week 3 and 4: 1-0-1, week 5: 1-0-2, week 6: 2-0-2. Patients may take 2 to 12 per day (200 - 1200 mg) during maintenance depending on tolerance and efficacy.

DRUG

Lamotrigine

LTG 25 mg encapsulated: week 1 and 2: 0-0-1, week 3 and 4: 1-0-1, week 5: 1-0-2, week 6: 2-0-2. Patients may take 2 to 12 caps. per day (50 - 300 mg)during maintenance depending on tolerance and efficacy.

Trial Locations (1)

55101

Department of Neurology, University of Mainz Medical Centre, Mainz

All Listed Sponsors
collaborator

UCB Pharma GmbH

INDUSTRY

lead

Johannes Gutenberg University Mainz

OTHER

NCT00438451 - Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs | Biotech Hunter | Biotech Hunter